MetaCap

Drugs Made In America Acquisition Corp. - Units Company Profile

NASDAQ: DMAAUFinancial ServicesShell CompaniesUSD

10.790.00 (0.00%)

At close: Sep 21, 4:00 PM ET · Delayed 15 min

Drugs Made In America Acquisition - Units at a glance

Drugs Made In America Acquisition Corp. - Units (NASDAQ: DMAAU) is a Shell Companies company in the Financial Services sector headquartered in New York, NY. Drugs Made In America Acquisition - Units is led by Mr. Roger Bendelac. The company's shares have traded publicly since 2025.

Its SEC Central Index Key (CIK) is 0002028614, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Drugs Made In America Acquisition - Units do?

Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.

Business description based on the company's public filings.

Company information

Legal name
Drugs Made In America Acquisition Corp. - Units
Ticker
NASDAQ: DMAAU
Industry
Shell Companies
CEO
Mr. Roger Bendelac
Headquarters
420 Lexington Avenue, New York, NY, United States
Phone
646 726 7074
IPO year
2025
SEC CIK
0002028614

Companies similar to Drugs Made In America Acquisition - Units

Related